Effects of Nicotine on Brain Activity as Measured by fMRI
NCT01037153 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2017-07-02
Summary
Background:
\- Nicotine addiction is common among people who smoke tobacco, and the addictive properties of nicotine make smoking cessation difficult even for people who want to quit. Research has shown that smoking causes changes in the brain that lead to addiction and craving, but more research is needed to determine how different doses of nicotine and different intervals of receiving nicotine affect brain function. A greater understanding of nicotine's effect on the brain, as studied through functional magnetic resonance imaging (fMRI), may improve the effectiveness of smoking cessation therapies and treatments.
Objectives:
\- To determine the effects of nicotine on brain function and chemistry in experienced cigarette smokers.
Eligibility:
\- Current smokers (at least 20 cigarettes per day for at least 1 year) between 18 and 50 years of age.
Design:
* The study involves five separate research experiments. Most participants will be involved in only one experiment.
* The experiments will evaluate brain activity and function using fMRI. Participants will be trained in a series of tests on cognitive function before beginning the experimental part of the study.
* Experiment 1: Participants will have three fMRI scan sessions after receiving different dose levels of intravenous nicotine.
* Experiment 2: Participants will have four fMRI scan sessions after receiving two doses of nicotine separated by 1/4, 1/2, 3, and 24 hours.
* Experiment 3: Participants will have two sets of nicotine injections separated by 45 minutes, with each injection series containing five rapid injections of small amounts of nicotine (to mimic five puffs on a cigarette).
* Experiment 4: Participants will have three fMRI sessions after receiving a single injection of nicotine at three different rates (over 15, 60, or 120 seconds). In addition there will be three more sessions involving a nicotine patch and a nicotine injection as well as a placebo session.
* Experiment 5: Participants will have three fMRI sessions that will involve looking at different kinds of pictures related to or not related to smoking after receiving a single injection of nicotine.
* Participants will also provide blood samples for further study....
Conditions
- Nicotine Dependence
- Drug Abuse
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-08-06
- Completion
- 2011-07-25
Countries
- United States
Study Locations
More Related Trials
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Brain Reaction to Treatment of Nicotine Dependence
NCT00108173 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Smoking Environments on Brain Reactivity
NCT03421210 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Craving and Abstinence From Cigarettes on Brain Metabolism in Smokers
NCT00267813 ·Status: COMPLETED ·Phase: NA
-
Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
NCT00934024 ·Status: COMPLETED ·Phase: NA
-
Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray
NCT01136642 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging in Tobacco Smokers During a Quit Attempt
NCT04055467 ·Status: COMPLETED ·Phase: PHASE1
-
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
NCT03713424 ·Status: RECRUITING ·Phase: PHASE2
-
Brain Nicotine Receptor Density in Veteran Smokers
NCT01721473 ·Status: COMPLETED
-
A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control
NCT00830739 ·Status: COMPLETED
-
Study of Smoking Abstinence
NCT01035632 ·Status: COMPLETED
-
Brain Nicotine Receptor Density & Response to Nicotine Patch
NCT01526005 ·Status: COMPLETED
-
Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism
NCT05947162 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
NCT00136747 ·Status: COMPLETED ·Phase: PHASE1
-
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960 ·Status: COMPLETED ·Phase: NA
-
Varenicline on Reward Responses and Cognition in Adolescent Smokers
NCT01624428 ·Status: COMPLETED ·Phase: PHASE1
-
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
NCT00429208 ·Status: UNKNOWN ·Phase: NA
-
Baclofen Effects in Cigarette Smokers
NCT01821560 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Non-invasive Brain Stimulation in Tobacco Use Disorder
NCT02776319 ·Status: UNKNOWN ·Phase: NA
-
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
NCT00136786 ·Status: COMPLETED ·Phase: PHASE1
-
Bupropion and Cigarette-Related Cues in Smokers
NCT03920319 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex
NCT05018117 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Nicotinic Receptor Levels After Stopping Smoking
NCT01704573 ·Status: COMPLETED
-
Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence
NCT00916721 ·Status: COMPLETED ·Phase: PHASE3